Eur Eye Res. Ahead of Print: EER-78941 | DOI: 10.14744/eer.2024.78941

Investigation of subtypes of diabetic macular edema refractory to Anti-VEGF treated with a single dose dexamethasone implant

Ayna Sariyeva Ismayılov, Burcu Kahkeci, Ahmet Metin Karğın, Mahmut Oğuz Ulusoy
Department Of Ophthalmology, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey

PURPOSE: To evaluate the subtypes of diabetic macular edema refractory to anti-VEGF treated with a single dose dexamethasone(DEX) implant.
METHODS: In this retrospective study, 81 patients (118eyes) with diabetic macular edema refractory to anti-VEGF treated with a single injection of DEX implant were evaluated. Diabetic macular edema was classified into four subtypes: diffuse macular edema(DME) (n=36 eyes), cystoid macular edema (CME) (n=40 eyes), serous retinal detachment (SRD) (n=20 eyes), cystoid macular degeneration (CMD) (n=22 eyes). Best-corrected visual acuity (BCVA) and central macular thickness (CMT) changes in 2,4 and 6 months were examined.
RESULTS: The baseline BCVA was significantly lower in CMD eyes compared with the CME eyes (p=0.005). The baseline CMT was significantly lower in CME eyes compared with CMD (n=0.002) and DME eyes (n=0.014). After the intravitreal DEX implant, BCVA increased significantly in the 2nd month in the SRD eyes (p=0.045), in the 4th month in the DME eyes (p=0.038), and in the 6th month in the CME eyes (p=0.014). BCVA changes in CMD eyes were not statistically significant for all months (p>0.05). The mean CMT of all groups decreased significantly in the 2nd month (p<0.001 for all). Δ CMT at 2 months was -231.20±221.12 µm in the SRD group, -112.97±141.02 µm in the CME group, -312.66±175.56 µm in the CMD group, and -190.77±173.04 µm in the DME group (p<0.001). According to posthoc Bonferroni analysis, ΔCMT was statistically significantly higher in CMD eyes than in CME eyes (p<0.001).
CONCLUSION: Different subtypes of diabetic macular edema suggest different etiopathogenesis and drug responses. The eyes with the fastest onset of both morphological and functional improvement of intravitreal DEX implant were eyes with SRD. Although anatomical improvement began early in CME and DME eyes (2nd month), functional recovery begins later (4th and 6th month). The eyes with the least functional recovery were the eyes with CMD.

Keywords: serous retinal detachment, diffuse macular edema, cystoid macular edema, cystoid macular degeneration, best corrected visual acuity, central macular thickness

---